Table 1 Clinical characteristic of the patients with COVID-19 at admission

Male [n (%)]

56/105 (53.3)

38/79 (48.1)

18/26 (69.2)

0.073

Age (year, IQR)

45.0 [33.5, 59.5]

(n = 105)

41.0 [33.0, 56.0]

(n = 79)

59.0 [48.5, 69.8]

(n = 26)

< 0.001

Disease duration (d, IQR)

5.0 [3.0, 8.0]

(n = 105)

4.0 [2.0, 7.0]

(n = 79)

7.0 [5.0, 10.25]

(n = 26)

0.005

Hospital stay (d, IQR)

22.0 [17.0, 31.5]

(n = 105)

20.0 [16.0, 28.0]

(n = 79)

31.5 [22.5, 35.5]

(n = 26)

0.001

Fatty liver by ultrasound [n (%)]

37/89 (41.6)

26/65 (40.0)

11/24 (45.8)

0.636

Hypertension [n (%)]

15/105 (14.3)

9/79 (11.4)

6/26 (23.1)

0.190

Diabetes [n (%)]

6/105 (5.7)

3/79 (3.8)

3/26 (11.5)

0.160

HBsAg (+) [n (%)]

0/22 (0)

0/14 (0)

0/8 (0)

–

Anti-HCV (+) [n (%)]

1/22 (0)

0/14 (0)

1/8 (12.5)

0.364

Heavy alcohol use [n (%)]

1/105 (1.0)

1/79 (1.3)

0/26 (0)

1.000

ALT (U/L, IQR)

23.5 [14.0, 36.0]

(n = 105)

22.0 [14.0, 34.5]

(n = 79)

27.8 [18.8, 38.0]

(n = 26)

0.088

  < 1 × ULN [n (%)]

88 (83.8)

67 (84.8)

21 (80.8)

0.482

1–2 × ULN [n (%)]

13 (12.4)

10 (12.7)

3 (11.5)

≥2 × ULN [n (%)]

4 (3.8)

2 (2.5)

2 (7.7)

AST (U/L, IQR)

24.2 [19.7, 34.8]

(n = 50)

22.0 [18.4, 31.7]

(n = 39)

46.3 [25.5, 54.3] (n = 11)

< 0.001

< 1 × ULN [n (%)]

41 (82.0)

37 (94.9)

4 (36.4)

< 0.001

1–2 × ULN [n (%)]

8 (16.0)

2 (5.1)

6 (54.5)

≥2 × ULN [n (%)]

1 (2.0)

0 (0)

1(9.1)

TBil (umol/L, IQR)

10.2 [7.4, 12.9]

(n = 50)

10.0 [7.1, 12.9]

(n = 39)

10.6 [8.3, 12.9] (n = 11)

0.535

< 1 × ULN [n (%)]

48 (96.0)

38 (97.4)

10 (90.9)

0.395

1–2 × ULN [n (%)]

2 (4.0)

1 (2.6)

1 (9.1)

≥2 × ULN [n (%)]

0 (0)

0 (0)

0 (0)

CHE (U/L, IQR)

7490 [6801, 9527] (n = 50)

6517 [6843, 9682] (n = 39)

6972 [4893, 8459] (n = 11)

0.137

ALB (g/L, IQR)

41.6 [37.9, 44.7]

(n = 49)

42.0 [38.7, 45.5]

(n = 39)

37.2 [34.2, 41.8] (n = 10)

0.012